NK Cell exhaustion

被引:229
作者
Bi, Jiacheng [1 ]
Tian, Zhigang [2 ,3 ,4 ]
机构
[1] Chinese Acad Sci, Shenzhen Inst Adv Technol, Inst Biomed & Biotechnol, Shenzhen Lab Antibody Engn, Shenzhen, Peoples R China
[2] Univ Sci & Technol China, Chinese Acad Sci, Sch Life Sci, Hefei, Peoples R China
[3] Univ Sci & Technol China, Chinese Acad Sci, Key Lab Innate Immun & Chron Dis, Med Ctr,Inst Immunol, Hefei, Peoples R China
[4] Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, State Key Lab Diag & Treatment Infect Dis, Affiliated Hosp 1,Coll Med, Hangzhou, Zhejiang, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2017年 / 8卷
关键词
tumors; chronic infections; immune evasion; immune checkpoints; immunotherapy; NATURAL-KILLER-CELLS; REGULATORY T-CELLS; ACUTE MYELOID-LEUKEMIA; INTERFERON-GAMMA PRODUCTION; HUMAN GASTRIC-CANCER; GROWTH-FACTOR-BETA; MULTIPLE-MYELOMA; SUPPRESSOR-CELLS; MEDIATED CYTOTOXICITY; DENDRITIC CELLS;
D O I
10.3389/fimmu.2017.00760
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Natural killer cells are important effector lymphocytes of the innate immune system, playing critical roles in antitumor and anti-infection host defense. Tumor progression or chronic infections, however, usually leads to exhaustion of NK cells, thus limiting the antitumor/infection potential of NK cells. In many tumors or chronic infections, multiple mechanisms might contribute to the exhaustion of NK cells, such as dysregulated NK cell receptors signaling, as well as suppressive effects by regulatory cells or soluble factors within the microenvironment. Better understanding of the characteristics, as well as the underlying mechanisms of NK cell exhaustion, not only should increase our understanding of the basic biology of NK cells but also could reveal novel NK cell-based antitumor/infection targets. Here, we provide an overview of our current knowledge on NK cell exhaustion in tumors, and in chronic infections.
引用
收藏
页数:10
相关论文
共 123 条
  • [11] IPH2101, a novel anti-inhibitory KIR antibody, and lenalidomide combine to enhance the natural killer cell versus multiple myeloma effect
    Benson, Don M., Jr.
    Bakan, Courtney E.
    Zhang, Shuhong
    Collins, Shauna M.
    Liang, Jing
    Srivastava, Shivani
    Hofmeister, Craig C.
    Efebera, Yvonne
    Andre, Pascale
    Romagne, Francois
    Blery, Mathieu
    Bonnafous, Cecile
    Zhang, Jianying
    Clever, David
    Caligiuri, Michael A.
    Farag, Sherif S.
    [J]. BLOOD, 2011, 118 (24) : 6387 - 6391
  • [12] The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody
    Benson, Don M., Jr.
    Bakan, Courtney E.
    Mishra, Anjali
    Hofmeister, Craig C.
    Efebera, Yvonne
    Becknell, Brian
    Baiocchi, Robert A.
    Zhang, Jianying
    Yu, Jianhua
    Smith, Megan K.
    Greenfield, Carli N.
    Porcu, Pierluigi
    Devine, Steven M.
    Rotem-Yehudar, Rinat
    Lozanski, Gerard
    Byrd, John C.
    Caligiuri, Michael A.
    [J]. BLOOD, 2010, 116 (13) : 2286 - 2294
  • [13] Hypoxic tumor-derived microvesicles negatively regulate NK cell function by a mechanism involving TGF- and miR23a transfer
    Berchem, Guy
    Noman, Muhammad Zaeem
    Bosseler, Manon
    Paggetti, Jerome
    Baconnais, Sonia
    Le Cam, Eric
    Nanbakhsh, Arash
    Moussay, Etienne
    Mami-Chouaib, Fathia
    Janji, Bassam
    Chouaib, Salem
    [J]. ONCOIMMUNOLOGY, 2016, 5 (04):
  • [14] Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine
    Beyer, M
    Kochanek, M
    Darabi, K
    Popov, A
    Jensen, M
    Endl, E
    Knolle, PA
    Thomas, RK
    von Bergwelt-Baildon, M
    Bebey, S
    Hallek, M
    Schultze, JL
    [J]. BLOOD, 2005, 106 (06) : 2018 - 2025
  • [15] T-Cell Ig and ITIM Domain Regulates Natural Killer Cell Activation in Murine Acute Viral Hepatitis
    Bi, Jiacheng
    Zhang, Qing
    Liang, Dan
    Xiong, Lei
    Wei, Haiming
    Sun, Rui
    Tian, Zhigang
    [J]. HEPATOLOGY, 2014, 59 (05) : 1715 - 1725
  • [16] Suppression of Metastases Using a New Lymphocyte Checkpoint Target for Cancer Immunotherapy
    Blake, Stephen J.
    Stannard, Kimberley
    Liu, Jing
    Allen, Stacey
    Yong, Michelle C. R.
    Mittal, Deepak
    Aguilera, Amelia Roman
    Miles, John J.
    Lutzky, Viviana P.
    de Andrade, Lucas Ferrari
    Martinet, Ludovic
    Colonna, Marco
    Takeda, Kazuyoshi
    Kuehnel, Florian
    Gurlevik, Engin
    Bernhardt, Guenter
    Teng, Michele W. L.
    Smyth, Mark J.
    [J]. CANCER DISCOVERY, 2016, 6 (04) : 446 - 459
  • [17] Enhancement of tumor cell susceptibility to natural killer cell activity through inhibition of the PI3K signaling pathway
    Bommarito, Davide
    Martin, Allison
    Forcade, Edouard
    Nastke, Maria-Dorothea
    Ritz, Jerome
    Bellucci, Roberto
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2016, 65 (03) : 355 - 366
  • [18] Activating NK cell receptor expression/function (NKp30, NKp46, DNAM-1) during chronic viraemic HCV infection is associated with the outcome of combined treatment
    Bozzano, Federica
    Picciotto, Antonino
    Costa, Paola
    Marras, Francesco
    Fazio, Valentina
    Hirsch, Ivan
    Olive, Daniel
    Moretta, Lorenzo
    De Maria, Andrea
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2011, 41 (10) : 2905 - 2914
  • [19] Metabolic Instruction of Immunity
    Buck, Michael D.
    Sowell, Ryan T.
    Kaech, Susan M.
    Pearce, Erika L.
    [J]. CELL, 2017, 169 (04) : 570 - 586
  • [20] Transforming growth factor β1 inhibits expression of NKp30 and NKG2D receptors:: Consequences for the NK-mediated killing of dendritic cells
    Castriconi, R
    Cantoni, C
    Della Chiesa, M
    Vitale, M
    Marcenaro, E
    Conte, R
    Biassoni, R
    Bottino, C
    Moretta, L
    Moretta, A
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (07) : 4120 - 4125